iView Therapeutics Inc.
Address：Pennsylvania USA; Zhuhai China
IVIEW was established by serial successful entrepreneurs in Pennsylvania Biotechnology Center, with offices and manufacturing facilities in Zhuhai, China. IVIEW has world-leading ophthalmic drug formulation platforms with intellectual property rights. Depending on the R&D strategy combining 505(b)1 & 2, business model combining independent R&D and license in/out strategy to enrich pipelines, and global market strategy by China-US dual registration, IVIEW has multiple innovative pipelines covering broad-spectrum antiophthalmic infections, xerophthalmia, myopia, and other unmet needs in ophthalmology.